INNOVA CAPTAB
Back to Balance Sheet
|
INNOVA CAPTAB Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹0.95 Cr | ₹-15 Cr | ₹3.80 Cr | ₹1.84 Cr | ₹1.93 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of INNOVA CAPTAB ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹0.95 Cr |
| Mar2024 | ₹-15 Cr |
| Mar2023 | ₹3.80 Cr |
| Mar2022 | ₹1.84 Cr |
| Mar2021 | ₹1.93 Cr |
How is Deferred Tax Assets / Liabilities of INNOVA CAPTAB Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹0.95 Cr | Positive | |
| Mar2024 | ₹-15 Cr | Negative | |
| Mar2023 | ₹3.80 Cr | 106.91 | |
| Mar2022 | ₹1.84 Cr | -4.62 | |
| Mar2021 | ₹1.93 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of INNOVA CAPTAB
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INNOVA CAPTAB | ₹4,890.9 Cr | -0.2% | 16.6% | -6.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹451,075.0 Cr | 0.4% | 10.8% | 10.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,486.0 Cr | 0.7% | 9.5% | 16.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹149,124.0 Cr | -2.5% | 6% | 36.2% | Stock Analytics | |
| CIPLA | ₹115,641.0 Cr | 9.7% | 16.7% | -4.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,589.0 Cr | 4.5% | 9.7% | 9% | Stock Analytics | |
INNOVA CAPTAB Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INNOVA CAPTAB | -0.2% |
16.6% |
-6.7% |
| SENSEX | -2.7% |
-2.1% |
-5.3% |
You may also like the below Video Courses